Menu
Subscribe to our Email Alerts
Home
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Amplia's Pipeline
Cancer Program
Fibrosis Program
Clinical Trial
Investor Information
Welcome
Investor Fact Sheet
Investor Presentations
Media
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Announcements and Reports
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
Contact Us
Contact Us
Email Alerts
Recent Posts
ACCENT Trial Recruitment Progress | Cohort 2 filled
Women in Science | Q&A with Dr Terrie-Anne Cock, Head of Translational Biology
35th Annual Lorne Cancer Conference, 9-11 February 2023
Channel 9 News | 3 February 2023
The Courier Mail | New hope for advanced pancreatic cancer patients in clinical trials
Archives
February 2023
January 2023
December 2022
November 2022
October 2022
September 2022
August 2022
July 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
September 2021
July 2021
June 2021
Categories
Company News
Media
Uncategorized
Videos
June 23rd, 2022
Navigating human research ethics
Read More
May 9th, 2022
ABC News | Bioshares
Read More
April 19th, 2022
QUARTERLY ACTIVITIES REPORT & 4C
Read More
April 7th, 2022
VIDEO | Proactive Investors Interview, Phase 2 Clinical Trial
Read More
April 5th, 2022
New investment in pancreatic cancer research
Read More
March 30th, 2022
Amplia is hiring
Read More
March 17th, 2022
Scientific rigour is in our DNA
Read More
February 17th, 2022
Improving Pancreatic Cancer Survival Rates
Read More
February 11th, 2022
WOMEN IN SCIENCE | Rhiannon Jones, Director, Operations
Read More
February 1st, 2022
VIDEO | PROACTIVE Amplia Therapeutics readies for phase two clinical trials and "watershed year" for AMP945
Read More
January 24th, 2022
Quarterly Report & 4C
Read More
December 2nd, 2021
$2.1M R&D Cash Flow Loan
Read More
November 30th, 2021
VIDEO | SMALL CAPS Amplia Therapeutics makes headway in anti-cancer clinical trial
Read More
November 18th, 2021
VIDEO | PROACTIVE Amplia Therapeutics details summary results from its phase 1 clinical trial of AMP945
Read More
November 17th, 2021
New Phase 1 Clinical Trial Data
Read More
November 10th, 2021
VIDEO | AUSBIZ Amplia's $12M plan; what's next for the Aussie medtech
Read More
November 10th, 2021
VIDEO | Proactive Investors, $12.4m Capital Raise
Read More
November 8th, 2021
$12.4m Capital Raise
Read More
October 26th, 2021
Amplia appoints leading drug developer as Oncology Clinical Advisor
Read More
October 21st, 2021
Switzer Daily | Therapeutics company primed for growth
Read More
1
2
3
4
